参考文献/References:
[1] 郭勇 , 龚建平 , 李培志.胰腺癌的综合治疗进展 [J].国际外科学杂志 , 2021, 48(9): 638-643. GUO Yong, GONG Jianping, LI Peizhi. Advances in the comprehensive treatment of pancreatic cancer[J]. International Journal of Surgery, 2021, 48(9): 638-643.
[2] LOWENFELS A B, MAISONNEUVE P, CAVALLINI G, et al. Pancreatitis and the risk of pancreatic cancer [J]. N Engl J Med, 1993, 328(20):1433-1437.
[3] 李超 , 朱晓丹 , 张玲华 , 等 .基于 GEO数据库整合 miRNA-mRNA表达谱筛选卵巢癌的关键基因分子及生物信息分析 [J].现代检验医学杂志 , 2021, 36(5): 38-42. LI Chao, ZHU Xiaodan, ZHANG Linghua, et al. Screening key biomarkers and bioinformatic analysis of ovarian cancer by integrated miRNA-mRNA expression profiles based on GEO database[J]. Journal of Modern Laboratory Medicine, 2021, 36(5): 38-42.
[4] 吴良银 , 李文丽 , 刘俊.基于 GEO数据的病毒相关性肝癌潜在生物基因标志物的筛选及生物信息学分析 [J].现代检验医学杂志 , 2021, 36(6): 106-110. WU Liangyin, LI Wenli, LIU Jun. Screening and bioinformatics analysis of potential biomarkers for virus-associated hepatocellular carcinoma based on GEO data[J]. Journal of Modern Laboratory Medicine, 2021, 36(6): 106-110.
[5] XIE J, WEN J T, XUE X J, et al. MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3[J]. European Review for Medical and Pharmacological Sciences, 2018, 22(7): 1914-1921.
[6] 高杰 , 张晓 , 魏超 .差异表达 miRNA在胰腺癌预后判断中的价值 [J].癌变·畸变·突变 , 2019, 31(3): 173-179. GAO Jie, ZHANG Xiao, WEI Chao. Involvement of differentially expressed miRNA in prognosis of pancreatic cancers[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2019, 31(3): 173-179.
[7] 胡应霞 , 张海蓉 , 石围 , 等.血浆 miR-155, miR-196a, miR-21和 miR-210对胰腺癌的早期诊断价值 [J]. 肿瘤 , 2015, 35(10): 1135-1143. HU Yingxia, ZHANG Hairong, SHI Wei, et al. Early diagnostic value of plasma miR-155, miR-196a, miR-21 and miR-210 in patients with pancreatic cancer[J]. Tumor, 2015, 35(10): 1135-1143.
[8] XIN Lei, GAO Jun, WANG Dan, et al. Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis[J]. Scientific Reports, 2017, 7: 40019.
[9] ZHANG Yuqing, LI Min, WANG Hao, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis[J]. World Journal of Surgery, 2009, 33(4): 698-709.
[10] WANG Lei, ZHENG Jianming, SUN Chang, et al. MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm[J]. Oncotarget, 2017, 8(35): 58765-58770.
[11] 孙莹莹 , 陆颖影 , 靖大道.慢性胰腺炎和胰腺癌发生及发展中肠道微生态的研究进展 [J].国际消化病杂志 , 2021, 41(4): 240-243. SUN Yingying, LU Yingying, JING Dadao. Research progress of intestinal microbiology in the development of chronic pancreatitis and pancreatic cancer [J]. International Journal of Digestive Diseases, 2021, 41(4): 240-243.
[12] WANG Hao, JIANG Yanfeng, LU Ming, et al. STX12 LncRNA/miR-148a/SMAD5 participate in the regulation of pancreatic stellate cell activation through a mechanism involving competing endogenous RNA[J]. Pancreatology, 2017, 17(2): 237-246.
[13] QI Z, ZHANG B, ZHANG J, et al. MicroRNA-30b inhibits non-small cell lung cancer cell growth by targeting the epidermal growth factor receptor[J]. Neoplasma, 2018, 65(2): 192-200.
[14] WANG Ning, XIANG Xiaohui, CHEN Kai, et al. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma[J]. Biochimie, 2018, 146: 56-67.
[15] LIU Wenjuan, LI Honghong, WANG Yan, et al. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma[J]. Gene, 2017, 626: 275-281.
[16] XIONG Yicheng, WANG Yao, WANG Lei, et al. MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells[J]. Journal of Cancer, 2018, 9(12): 2147-2159.
[17] WHITE E, MEHNERT J M, AUTOPHAGY C C. Metabolism and cancer[J]. Clin Cancer Res, 2015, 21(22): 5037-5046.
[18] MAERTIN S, ELPERIN J M, LOTSHAW E, et al. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges[J]. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2017, 313(5): G524-G536.
[19] ENDO S, NAKATA K, OHUCHIDA K, et al. Autophagy is required for activation of pancreatic stellate cells, associated with pancreatic cancer progression and promotes growth of pancreatic tumors in mice[J]. Gastroenterology, 2017, 152(6): 1492-1506, e24.
[20] KWON J J, WILLY J A, QUIRIN K A, et al. Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential[J]. Oncotarget, 2016, 7(44): 71635-71650.
[21] HU Chunling, HART S N, POLLEY E C, et al. Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer[J]. JAMA , 2018, 319(23): 2401-2409.
[22] 臧龙军 , 陈东杰 , 高文哲 , 等 .长链非编码 RNA SOX21-AS1调控 miR-31-5p/MMP-16轴对胰腺癌细胞活性与增殖的影响 [J].中国普通外科杂志 , 2022, 31(3): 329-339. ZANG Longjun, CHEN Dongjie, GAO Wenzhe, et al. Effect of long non-coding RNA SOX21-AS1 on viability and proliferation of pancreatic cancer cells via modulating miR-31-5p/MMP-16 axis[J]. Chinese Journal of General Surgery, 2022, 31(3): 329-339.
[23] 王东琴 , 霍浩然 , 秦瑞峰 , 等 .胰腺癌患者血清 LncRNA-SNHG11的表达水平及其临床意义 [J].现代检验医学杂志 , 2022, 37(1): 125-129, 144. WANG Dongqin, HUO Haoran, QIN Ruifeng, et al. Expression level of serum LncRNA-SNHG11 in patients with pancreatic cancer and its clinical significance[J]. Journal of Modern Laboratory Medicine, 2022, 37(1): 125-129, 144.
[24] LIU Hao, YU Kaihuan, MA Peng, et al. Long noncoding RNA myocardial infarction-associated transcript regulated the pancreatic stellate cell activation to promote the fibrosis process of chronic pancreatitis[J]. Journal of Cellular Biochemistry, 2019, 120(6): 9547-9555.
[25] ZHOU Wenyang, ZHANG Mingming, LIU Chang, et al. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p[J]. Journal of Cellular Physiology, 2019, 234(12): 23176-23189.
相似文献/References:
[1]党珊a,周健a,杨帆b,等.胰腺癌组织中缺氧诱导因子-2α的表达及临床意义[J].现代检验医学杂志,2015,30(06):32.[doi:10.3969/j.issn.1671-7414.2015.06.009]
DANG Shana,ZHOU Jiana,YANG Fanb,et al.Expression of Hypoxia Inducible Factor 2α in Pancreatic
Carcinoma and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2015,30(02):32.[doi:10.3969/j.issn.1671-7414.2015.06.009]
[2]韦 莉,缪淑贤,王 敏,等.胰腺癌患者血清尿酸、肌酐水平检测及尿酸/肌酐比值的临床意义[J].现代检验医学杂志,2019,34(04):99.[doi:10.3969/j.issn.1671-7414.2019.04.024]
WEI Li,MIAO Shu-xian,WANG Min,et al.Clinical Significance of Serum Uric Acid,Creatinine
and Uric Acid/Creatinine Ratio in Pancreatic Ductal Adenocarcinoma[J].Journal of Modern Laboratory Medicine,2019,34(02):99.[doi:10.3969/j.issn.1671-7414.2019.04.024]
[3]邢瑞青,彭道荣,刘 杨.血清CA199,KL-6和PIVKA-Ⅱ水平联合检测在胰腺癌诊断中的应用价值分析[J].现代检验医学杂志,2021,36(05):100.[doi:10.3969/j.issn.1671-7414.2021.05.022]
XING Rui-qing,PENG Dao-rong,LIU Yang.Application Value of Combined Detection of Serum CA199,KL-6 andPIVKA -Ⅱ Levels in the Diagnosis of Patients with Pancreatic Cancer[J].Journal of Modern Laboratory Medicine,2021,36(02):100.[doi:10.3969/j.issn.1671-7414.2021.05.022]
[4]王东琴,霍浩然,秦瑞峰,等.胰腺癌患者血清 lncRNA-SNHG11的表达水平及其临床意义[J].现代检验医学杂志,2022,37(01):125.[doi:10.3969/j.issn.1671-7414.2022.01.025]
WANG Dong-qin,HUO Hao-ran,QIN Rui-feng,et al.Expression Level of Serum lncRNA-SNHG11 in Patients with Pancreatic Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(02):125.[doi:10.3969/j.issn.1671-7414.2022.01.025]
[5]王军堂a,齐普良a,张金刚a,等.hsa_circ_0006950 调控miR-124-3p/EZH2 轴促进胰腺癌细胞增殖与迁移的机制研究[J].现代检验医学杂志,2022,37(05):93.[doi:10.3969/j.issn.1671-7414.2022.05.019]
WANG Jun-tanga,QI Pu-lianga,ZHANG Jin-ganga,et al.Mechanism of hsa_circ_0006950 Regulating miR-124-3p /EZH2 Axis to Promote the Proliferation and Migration of Pancreatic Cancer Cells[J].Journal of Modern Laboratory Medicine,2022,37(02):93.[doi:10.3969/j.issn.1671-7414.2022.05.019]
[6]张莉娜,张霁雯,罗 酩,等.胰腺癌组织CTTN 和miR-545-3p 表达水平及其与临床病理和预后的相关性研究[J].现代检验医学杂志,2022,37(06):99.[doi:10.3969/j.issn.1671-7414.2022.06.018]
ZHANG Li-na,ZHANG Ji-wen,LUO Ming,et al.Expression Levels of CTTN and miR-545-3p in Pancreatic Cancer Tissues and Their Correlation with Clinicopathology and Prognosis[J].Journal of Modern Laboratory Medicine,2022,37(02):99.[doi:10.3969/j.issn.1671-7414.2022.06.018]
[7]檀占海,陈建荣,张吉发,等.胰腺癌组织中METTL14 和GFPT1 的水平表达与临床预后价值研究[J].现代检验医学杂志,2023,38(05):99.[doi:10.3969/j.issn.1671-7414.2023.05.019]
TAN Zhanhai,CHEN Jianrong,ZHANG Jifa,et al.Expression of METTL14 and GFPT1 in Pancreatic Cancer and Their Clinical Prognostic Value[J].Journal of Modern Laboratory Medicine,2023,38(02):99.[doi:10.3969/j.issn.1671-7414.2023.05.019]
[8]夏菊芳,刘 洪.胰腺癌组织中KYNU mRNA 的表达及其与免疫浸润和预后的相关性研究[J].现代检验医学杂志,2024,39(02):57.[doi:10.3969/j.issn.1671-7414.2024.02.011]
XIA Jufang,LIU Hong.Expression of KYNU mRNA in Pancreatic Cancer Tissue and Its Correlation with Immune Infiltration and Prognosis[J].Journal of Modern Laboratory Medicine,2024,39(02):57.[doi:10.3969/j.issn.1671-7414.2024.02.011]